TapImmune to Present at 2018 Disruptive Growth & Healthcare Conference

JACKSONVILLE, Florida, May 1, 2018 – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Disruptive Growth & Healthcare Conference, held May 8-9, 2018 at Reed Smith LLP in New York City.   Disruptive Growth & Healthcare Conference Disruptive ImmunoTherapies Panel Date: Wednesday, May 9th, 2018 Time: 9:30 AM ET Location: Track 2 | Room C/D Webcast: https://www.webcaster4.com/Webcast/Page/1861/25809   TapImmune Company Presentation Date: Wednesday, May 9th, 2018 Time: 11:35 AM ET Location: Track 1 | Room A/B[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer]